IL17/IL17RA as a Novel Signaling Axis Driving Mesenchymal Stem Cell Therapeutic Function in Experimental Autoimmune Encephalomyelitis

The therapeutic effect of mesenchymal stem cells (MSCs) in multiple sclerosis (MS) and the experimental autoimmune encephalomyelitis (EAE) model has been well described. This effect is, in part, mediated through the inhibition of IL17-producing cells and the generation of regulatory T cells. While p...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Mónica Kurte, Patricia Luz-Crawford, Ana María Vega-Letter, Rafael A. Contreras, Gautier Tejedor, Roberto Elizondo-Vega, Luna Martinez-Viola, Catalina Fernández-O’Ryan, Fernando E. Figueroa, Christian Jorgensen, Farida Djouad, Flavio Carrión
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2018-04-01
coleção:	Frontiers in Immunology
Assuntos:	cellular therapy experimental autoimmune encephalomyelitis mesenchymal stem cells IL17 IL17RA
Acesso em linha:	http://journal.frontiersin.org/article/10.3389/fimmu.2018.00802/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!